Survival of antiarrhythmic or implantable cardioverter defibrillator treated patients with varying degrees of left ventricular dysfunction who survived malignant ventricular arrhythmias

Journal of Cardiovascular Electrophysiology

Volumn 13, Issue 6, 2002, Pages 580-583

  Domanski, Michael J ^a   Epstein, Andrew ^b   Hallstrom, Al ^c   Saksena, Sanjeev ^d,f   Zipes, Douglas P ^e,f  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Atlantic Health   (United States)

^e INDIANA UNIVERSITY   (United States)

^f MEDTRONIC INC   (United States)

Author keywords

Implantable cardioverter defibrillator; Sudden cardiac death; Ventricular arrhythmia

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; SURVIVAL RATE; COMPARATIVE STUDY; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HOSPITALIZATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; SURVIVAL; TREATMENT OUTCOME;

AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0035991576     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2002.00580.x     Document Type: Article

References (11)

1. Resuscitation from out-of-hospital ventricular fibrillation: 4 year follow-up
2. Predictive survival models for resuscitated victims of out-of-hospital cardiac arrest with coronary heart disease
3. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias
4. Implantable cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias
5. Antiarrhythmics Versus Implantable Defibrillators (AVID): Rationale, design, and methods
6. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations
7. Randomized trial of the effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction
8. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study)
9. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg)
10. The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias
11. Randomized study of implantable cardioverter-defibrillator as first choice therapy versus conventional strategy in post-infarct sudden death survivors